Ganly Ian, Gross Neil D, Patel Snehal G, Bilsky Mark H, Shah Jatin P, Kraus Dennis H
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Head Neck. 2007 Feb;29(2):89-94. doi: 10.1002/hed.20487.
Craniofacial resection (CFR) for patients over 70 years of age is uncommon. This study examines a cohort of 36 patients who had CFR at a single institution with the aim of reporting mortality, complications, and outcome.
Thirty-six patients 70 years of age and older were identified from a prospective database of 234 patients who had CFR at a single institution. The median age was 72 years (range, 70-87). Seventeen (47%) patients had had prior single-modality or combined treatment, which included surgery in 14 (40%), radiation in 13 (36%), and chemotherapy in 2 (6%). Thirty-five patients had a malignant tumor and 1 patient a benign tumor; 15 (42%) had high-grade, 17 (47%) intermediate-grade, and 4 (11%) low-grade pathology. The margins of resection were close or microscopically positive in 18 (50%). Adjuvant radiotherapy was given in 15 (42%) and chemotherapy in 1 (3%). Complications were classified into overall, local, central nervous system (CNS), systemic, and orbital. Overall survival (OS) and disease-specific survival (DSS) were determined using the Kaplan-Meier method. Outcomes were compared with patients less than 70 years of age.
Postoperative mortality occurred in 6 (17%) patients and postoperative complications occurred in 23 (64%) patients. Local wound complications occurred in 11 (30%), CNS in 12 (33%), systemic in 6 (17%), and orbital in 1 (3%). Postoperative mortality and complications were significantly higher in patients 70 years of age and older compared with patients less than 70 years of age (17% versus 1.5%, p = .0005; 64% versus 36%, p = .003, respectively). With a median follow-up of 27 months (range, 1-237), the 3 year OS and DSS were significantly poorer than patients less than 70 years of age (OS: 53% versus 69%, p = .0004; DSS: 61% versus 70%, p = .01) due to increased medical comorbidity (53% versus 24%, p = .001) and poorer histology (high-, intermediate-, low-grade histology: 42%, 47%, 11% versus 26%, 47%, 27%, p = .05, respectively) in patients over 70 years of age.
CFR in patients 70 years of age and older is associated with increased mortality, increased incidence of complications, and a poorer overall and disease-specific 3-year survival, compared with patients less than 70 years of age. The survival was likely due to increased medical comorbidity and adverse histology. These factors must be taken into account when considering an elderly patient for craniofacial resection.
对70岁以上患者进行颅面切除术(CFR)并不常见。本研究调查了在单一机构接受CFR的36例患者,旨在报告死亡率、并发症及治疗结果。
从一个前瞻性数据库中识别出36例70岁及以上在单一机构接受CFR的患者。中位年龄为72岁(范围70 - 87岁)。17例(47%)患者曾接受过单一模式或联合治疗,其中14例(40%)接受过手术,13例(36%)接受过放疗,2例(6%)接受过化疗。35例患者患有恶性肿瘤,1例患者患有良性肿瘤;15例(42%)为高级别病理,17例(47%)为中级别病理,4例(11%)为低级别病理。18例(50%)患者的切除切缘接近或显微镜下呈阳性。15例(42%)患者接受了辅助放疗,1例(3%)患者接受了化疗。并发症分为总体并发症、局部并发症、中枢神经系统(CNS)并发症、全身并发症和眼眶并发症。采用Kaplan-Meier法确定总生存期(OS)和疾病特异性生存期(DSS)。将结果与70岁以下患者进行比较。
6例(17%)患者发生术后死亡,23例(64%)患者发生术后并发症。局部伤口并发症发生在11例(30%),CNS并发症发生在12例(33%),全身并发症发生在6例(17%),眼眶并发症发生在1例(3%)。70岁及以上患者的术后死亡率和并发症发生率显著高于70岁以下患者(分别为17%对1.5%,p = 0.0005;64%对36%,p = 0.003)。中位随访27个月(范围1 - 237个月),3年OS和DSS显著低于70岁以下患者(OS:53%对69%,p = 0.0004;DSS:61%对70%,p = 0.01),原因是70岁以上患者的医疗合并症增加(53%对24%,p = 0.001)以及组织学较差(高级别、中级别、低级别组织学:42%、47%、11%对26%、47%、27%,p = 0.05)。
与70岁以下患者相比,70岁及以上患者进行CFR与死亡率增加、并发症发生率增加以及3年总生存期和疾病特异性生存期较差相关。生存情况可能归因于医疗合并症增加和不良组织学。在考虑对老年患者进行颅面切除术时,必须考虑这些因素。